FDA Moves Israeli COVID-19 Treatment With 100% Survival Rate Into Clinical Trials

Corona Virus Pluristem Treatment

"According to the Jerusalem Post, the company Pluristem created a placenta-based cell-therapy that has not only helped patients survive but also improve respiratory parameters to boot. These patients were in dire straights while being tested with organ failures across the board"

Be the first to comment

Please check your e-mail for a link to activate your account.